What is it?
What Polygala tenuifolia is
7Polygala tenuifolia is a traditional medicinal root used in East Asian herbal systems, commonly called Yuan Zhi in Chinese materia medica and Onji in Japanese contexts. Modern supplement listings may be raw root, extracts, standardized BT-11-style extracts, or multi-herb blends.
Two small, older BT-11 studies are preliminary
3Two 2009 human papers reported memory or cognitive findings with BT-11, a standardized Polygala tenuifolia root extract, in healthy and older participants. They are small, older, extract-specific studies. They do not establish reliable focus, mood, sleep, or disease-care effects, and they do not validate raw-root powders, tinctures, or multi-herb products.
Names, aliases and forms
Mechanisms of action
Cholinergic and neurotrophic hypotheses
5Preclinical Polygala research discusses cholinergic signaling, acetylcholinesterase-related activity, neurotrophic pathways, saponins, and oligosaccharide esters. These mechanisms are plausible context for memory research, not proof that every Polygala product improves cognition.
Potential effects and evidence map
Polygala tenuifolia has a small, extract-specific human literature. Two 2009 papers reported memory or cognitive findings for BT-11, a standardized Polygala tenuifolia root extract, in healthy and older participants; these older studies are preliminary and do not validate generic Polygala products. A randomized 12-week adolescent safety study assigned 61 participants to BT-11 300 mg/day and 60 to placebo, with no apparent product-related adverse reactions, but it does not establish efficacy, long-term safety, pregnancy/lactation safety, or raw-root equivalence. Cholinergic, neurotrophic, and stress-related mechanisms are mainly preclinical. Overall, human evidence is limited and form-specific.
Two small, older 2009 studies of standardized BT-11 reported memory or cognitive findings; the evidence is preliminary and extract-specific.
Focus and attention support are not well established beyond limited memory-oriented BT-11 findings.
Traditional calming use and preclinical CNS mechanisms do not establish reliable human calm or anxiety benefits.
No reliable human sleep-quality benefit has been established for Polygala tenuifolia.
Typical dosages and timing
A randomized adolescent BT-11 safety study used 300 mg/day for 12 weeks and found no apparent product-related adverse reactions. This does not establish a consumer cognitive dose, long-term safety, or equivalence to raw root, tinctures, or other extracts.
Timing & effect horizon
Polygala does not have a reliable acute nootropic timing profile. Human work is better read as short-study extract context rather than a same-day focus protocol.
Safety, side effects and risk profile
Polygalae Radix saponins are associated with gastrointestinal irritation concerns in the review literature.
Traditional calming/sedative positioning and CNS-active mechanisms make additive sedation or impairment plausible, especially with sedatives, alcohol, or sleep aids.
Use caution with sedatives, alcohol, cholinergic drugs, anticholinergic drugs, antidepressants, anticonvulsants, dementia medications, or multi-herb formulas.
Pregnancy, attempts to conceive, lactation, and pediatric use outside studied contexts should avoid unsupervised concentrated Polygala extract.
Evidence is form-specific: BT-11 data, raw-root powders, decoctions, tinctures, and multi-herb formulas should not be assumed interchangeable.
Headache, dizziness, or unusual CNS effects should prompt stopping and review, especially when Polygala is combined with other CNS-active products.
Polygala is CNS-active enough that stacking it with sedatives, alcohol, sleep aids, antidepressants, dementia medications, anticholinergics, cholinergics, anticonvulsants, or multiple calming herbs deserves professional review.
The BT-11 adolescent safety study does not establish pregnancy, lactation, infant, or broad pediatric safety. Concentrated extracts should be avoided in these contexts unless a qualified clinician reviews the exact product.
Legal and regulatory status
In the United States, FDA generally does not approve dietary supplements or their labeling before marketing. Online availability or a traditional-use history does not mean a Polygala product is FDA-approved for cognitive, psychiatric, or disease claims; laws outside the United States vary.
Practical buying and quality notes
- Prefer products that clearly state root part, extract ratio, standardization marker, BT-11 status if claimed, batch testing, and processing method. A bare Polygala label is not enough to compare against the human memory studies.3
- Price per gram of raw root and price per milligram of standardized extract answer different questions. Compare like with like, and do not assume low-cost powder matches the studied BT-11 extract.7
FAQ
Is Polygala tenuifolia a reliable memory supplement?
3It has limited human BT-11 evidence for memory-related outcomes, but reliability depends on extract identity and the evidence is not broad enough for every Polygala product.
How should a Polygala label be compared?
7Compare the exact root material, extract ratio, marker compounds, processing, serving size, and whether the product actually identifies BT-11. Raw root, decoctions, tinctures, and multi-herb products need separate evaluation.
Does Polygala help focus or mood?
3Focus and mood support are not well established in humans. The best human signal is memory-oriented and extract-specific.
Why mention GI irritation?
7Polygala saponins can irritate the gastrointestinal tract, and review literature notes that dose, processing, and combination with other herbs can affect this limitation.
Can Polygala replace dementia or anxiety care?
7No. Polygala research does not make it a substitute for qualified medical assessment or care for cognitive decline, anxiety, insomnia, depression, neurologic symptoms, pregnancy, or complex medication use.
References
- NCBI Taxonomy. Polygala tenuifolia Willd., Taxonomy ID 355332. Accessed 2026-06-30.
- PubChem. Tenuifolin, CID 21588226. Accessed 2026-06-30.
- Lee JY, Kim KY, Shin KY, Won BY, Jung HY, Suh YH. Effects of BT-11 on memory in healthy humans. Neuroscience Letters. 2009;454(2):111-114.
- Shin KY, Lee JY, Won BY, Jung HY, Chang KA, Koppula S, Suh YH. BT-11 is effective for enhancing cognitive functions in the elderly humans. Neuroscience Letters. 2009;465(2):157-159.
- Park CH, Choi SH, Koo JW, et al. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. Journal of Neuroscience Research. 2002;70(3):484-492.
- Choi JG, Kim N, Huh E, et al. Study on the safety of Polygala tenuifolia Willdenow root extract powder (BT-11) in young person aged from 9 to 19 years old. Journal of Ethnopharmacology. 2019;237:123-129.
- Zhou X, et al. A review of the botany, metabolites, pharmacology, toxicity, industrial applications, and processing of Polygalae Radix: the key medicine for nourishing life. Frontiers in Pharmacology. 2024;15:1450733.
- Liu P, et al. Active constituent of Polygala tenuifolia attenuates cognitive deficits by rescuing hippocampal neurogenesis in APP/PS1 transgenic mice. BMC Complementary Medicine and Therapies. 2021;21:267.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Accessed 2026-08-21.